Your browser doesn't support javascript.
loading
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
Nyffenegger, Naja; Zennadi, Rahima; Kalleda, Natarajaswamy; Flace, Anna; Ingoglia, Giada; Buzzi, Raphael M; Doucerain, Cédric; Buehler, Paul W; Schaer, Dominik J; Dürrenberger, Franz; Manolova, Vania.
Afiliação
  • Nyffenegger N; Vifor (International) Ltd., St. Gallen, Switzerland.
  • Zennadi R; Division of Hematology and Duke Comprehensive Sickle Cell Center, Duke University School of Medicine, Durham, NC.
  • Kalleda N; Vifor (International) Ltd., St. Gallen, Switzerland.
  • Flace A; Vifor (International) Ltd., St. Gallen, Switzerland.
  • Ingoglia G; Vifor (International) Ltd., St. Gallen, Switzerland.
  • Buzzi RM; Division of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland; and.
  • Doucerain C; Vifor (International) Ltd., St. Gallen, Switzerland.
  • Buehler PW; University of Maryland, School of Medicine, Baltimore, MD.
  • Schaer DJ; Division of Internal Medicine, University Hospital and University of Zurich, Zurich, Switzerland; and.
  • Dürrenberger F; Vifor (International) Ltd., St. Gallen, Switzerland.
  • Manolova V; Vifor (International) Ltd., St. Gallen, Switzerland.
Blood ; 140(7): 769-781, 2022 08 18.
Article em En | MEDLINE | ID: mdl-35714304
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemólise / Anemia Falciforme Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemólise / Anemia Falciforme Limite: Animals Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça